Adverse effects on carbohydrate and lipid metabolism

In diabetic women who smoke, and in women with type 1 diabetes levonorgestrel –intrauterine device should be liberalized. To take in account the integration with diabetes control(medical or dietetic) and a weight control are mandatory. Particularly, primary preconception counseling for type 1 diabetes is convenient might be performed in the adolescent patients (27,28,29).

Rosa Sabatini and Loverro Giuseppe


  1.   Hilal.  (1985). Oral   contraception   and   carbohydrate   metabolism-the physiopathological   explanation.  Contracept.Fertil.  Sex.(Paris).  13(12), 1213-7.
  2.   Elkind-Hirsch,  K.,  Goldzieher,  J.W.  (1994).  Metabolism:carbohydrate metabolism.In :  Goldzieher,  J.W.,  Fotherby,  K.editors. Pharmacology of contraceptive steroids.New York, USA:Raven Press, p.345-56.
  3.   Sheu,  W.H.,  Hsu,  C.H.,Chen,  Y.S.,  Jeng,  C.Y.,  Fuh,  M.M.  (1994). Prospective evaluation of insulin resistance and lipid metabolism in women receiving oral contraceptives.Clin. Endocrinol,(Oxf) 40(2), 249-55.
  4.   Godsland,  I.F.,Crook,  D.,  Simpson,  R.  (1990). The effects of different formulations of oral contraceptives agents on lipid and carbohydrate metabolism. N.Engl.J.Med, 323,1375-81.
  5.   Rubio-Lotvin,  B.  (1996).Oral hormonal contraceptives and carbohydrate metabolism. Ginecol. Obstet. Mex, 64, 198-200. 
  6.   Crook,  D.,Godsland,  I.F.,Worhington,  M.,  Felron,  C.V.,  Proudler,  A.J., Stevenson, J.C. (1993). A comparative metabolic study of two low-estrogen dose oral contraceptives containing desogestrel or gestodene progestins.Am.J.Obstet.Gynecol, 169,1183-9.
  7.   Petersen, K.R., Skouby, S.O., Jepsen, P.V., Haaber, A.B. (1996). Diabetes regulation and oral contraceptives.Lipoprotein metabolism in women with insulin dependent diabetes mellitus using oral contraceptives. Ugerskr. Laeger, 158(17),2388-92. 
  8.   Endrikat, J., Klipping, C., Cronin, M., Gerlinger, C., Ruebig, A., Schmidt, W., Dusterberg, B. (2002).An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic,  lipids,  and carbohydrate metabolism variables. Contraception, Mar, 65(3), 215-21.
  9.   Skouby,  S.O.,  Endrikat,  J.,  Dusterberg,  B.,  Schmidt,  W.,  Gerlinger,  C., Wessel, J., Goldstein, H., Jespersen, J. (2005). A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism:  20 microg ethinyl estradiol combined with 100 microg levonorgestrel. Contraception, Feb, 71(2), 111-7. 
  10.   Xiang,  A.H.,  Kawakubo,  M.,  Buchanan,  T.A.,  Kjos,  S.L.  (2007).  A longitudinal study of lipids and blood pressure in relation to method of contraception in Latino women with prior gestational diabetes mellitus. Diabetes Care, 30(8), 1952-8. 
  11.   Petersen,  K.R.,  Skouby,  S.O.,  Jespersen,  J.  (1996). Contraception guidance in women with pre-existing disturbances in carbohydrate metabolism.Eur.J.Contracept.Reprod.HealthCare, 1(1), 53-9.
  12.   Charron-Prochownik, D., Sereika, S.M., Wang, S.L., Hannan, M.F., Fischl, A.R.,  Stewart,  S.H.,  Dean-McElhinny,  T.  (2006).Reproductive health and preconception counseling awareness in adolescents with diabetes: what they don’t know can hurt them. Diabetes Educ, Mar-Apr, 32(2), 235-42. 
  13.   Rogovskaya,  S.,  Rivera,  R.,  Grimes,  D.A.,  Chen,  P.L.,  Pierre-Louis,  B., Prilepskaya, V., Kulakov, V. (2005).Effect of a levonorgestrel intrauterine system on women with type 1 diabetes: a randomized trial. Obstet Gynecol, Apr, 105(4), 811-5. 
  14.   Gaspard,  U.,  Endrikat,  J.,  Desager,  J.P.,  Buicu,  C.,  Gerlinger,  C., Heithecker,  R.  (2004).  A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles. Contraception, 69(4), 271-8.
  15.   Cirkel,  U.,  Belkien,  L.,  Hanker,  J.P.,  Schweppe,  K.W.,  Schneider,  H.P. (1986). Effects of a chlormadinone acetate-containing ovulation inhibitor on androgenization pictures and liver and lipid metabolism in young females. Geburtshilfe Frauenheilkd, Jul, 46(7), 439-43
  16.   Zahradnik,  H.P.,  Hanjalic   Beck,  A.  (2008).  Efficacy, safety   and sustainability of treatment continuation and results of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg chlormadinone acetate, in long-term usage (up to 45 cycles)-an open label, prospective, noncontrolled, office-based Phase III study. Contraception, 77(5), 337-43.
  17.   Diab, K.M., Zaki, M.M. (2000). Contraception in diabetic women:comparative metabolic study of Norplant, depot-medroxyprogesterone acetate,low-dose oral contraceptive pill and CuT 380A. J.Obstet.Gynecol.Res, 26(1), 17-26. 
  18.   Grigoryan,  O.R., Grodnitskaya,  E.E.,  Andreeva,  E.N.,Chebotnikova,  T.V., Melnichenko, G.A. (2008). Use of the NuvaRing hormone-releasing system in   late   reproductive-age   women   with   type   1   diabetes   mellitus . Gynecol.Endocrinol, 24(2), 99-104.
  19.   Tuppurainem,  M.  (2004).  The combined contraceptive vaginal ring and lipid metabolism:a comparative study.Contraception, 69,389-94
  20.   Duijkers,  I.  (2004).  A comparative study on the effects of a contraceptive vaginal ring and an oral contraceptive on carbohydrate metabolism and adrenal and thyroid function.  Eur.  J.Contracept.Reprod.Health Care,  9, 131-40.
  21.   Lopez,  L.M., Grimes,  D.A.,  Schulz,  K.F.  (2007).  Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus. Cochrane Database Syst Rev,Apr, 18,(2), CD006133. 
  22.   Gaspard,  U.  (1988).Oral contraception, glucid metabolism and monitoring criteria. Contracept. Fertil. Sex(Paris),16(2), 113-
  23.   Nikolov, A., Dimitrov, A., Kolarov, G., Todarova, K., Mekhandzhiev, T.S. (2005). Contraception in women with diabetes mellitus. Akush Ginekol(Sofia), 44(5), 47-52
  24.   Skouby,  S.O.,  Molsted-Pedersen,  L.,  Petersen,  K.R.  (1991). Contraception for women with diabetes:an update. Baillieres Clin.Obstet.Gynaecol,  5(2), 493-503.
  25.   Falsetti,  D.,Charron-Prochownik,  D.,  Serelka,  S.,  Kitutu,  J.,  Peterson,  K., Becker,  D.,  Jacober,  S.,  Mansfield,  J.,White,  N.H.  (2003). Condom use,pregnancy,and STDs in adolescent females with and without type 1 diabetes.Diabetes Educ, 29(1), 135-43. 
  26.   Rogowicz,  A.,  Zozulinska,  D.,  Wierusz-Wysocka,  B.  (2007). Myocardial infarction in a 26-year old patient with diabetes type 1. Kardiol. Pol, 65(11), 1363-6.
  27.   Klinke,  J.,  Toth,  E.  L.  (2003).  Preconception care for women with type 1 diabetes. Can.Fam.Physician, 49, 769-73.
  28.   Diabetes and Pregnancy Grroup.  (2005).  Knowledge about preconception care in French women with type 1 diabetes.Diabetes Metab, 31(5), 443-7.
  29.   Charron-Prochownik, D., Sereika, S.M., Wang, S.L., Hannan, M.F., Fischi, A.R., Stewart, S.H., Dean – McElhinny, T. (2006). Reproductive health and preconception counseling awareness in adolescents with diabetes: what they don’t know can hurt them.Diabetes Educ, 32(2), 235-42.

Page 4 of 4« First 2 3 4

Provided by ArmMed Media